Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Farooq, Hamzah Z. ; Cirillo, Daniela M. ; Hillemann, Doris ; Wyllie, David ; van der Werf, Marieke J. ; Ködmön, Csaba ; Nikolayevskyy, Vlad
• Description:
  We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and repurposed tuberculosis drugs exists, but its availability is limited.
• Subjects:
  Antitubercular Agents Diarylquinolines Humans Microbial Sensitivity Tests Mycobacterium Tuberculosis Pharmaceutical Preparations Tuberculosis, Multidrug-Resistant
• Source:
  Emerg Infect Dis. 27(3):985-987
• Pubmed ID:
  33622487
• Pubmed Central ID:
  PMC7920658
• Document Type:
  Journal Article
• Place as Subject:
  Europe
• Volume:
  27
• Issue:
  3
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:1be607229e725fe3e48e01ab38926e15640b18c905025a870bb1b958466ee092
• Download URL:
  https://stacks.cdc.gov/view/cdc/104054/cdc_104054_DS1.pdf
• File Type:
  [PDF - 630.67 KB ]